Mechanisms underlying the blood pressure lowering effects of dapagliflozin, exenatide, and their combination in people with type 2 diabetes: a secondary analysis of a randomized trial
van Ruiten, Charlotte C, Smits, Mark M, Kok, Megan D, Serné, Erik H, van Raalte, Daniël H, Kramer, Mark H H, Nieuwdorp, Max, IJzerman, Richard G
Published in Cardiovascular diabetology (28.04.2022)
Published in Cardiovascular diabetology (28.04.2022)
Get full text
Journal Article
Renal haemodynamic and protective effects of renoactive drugs in type 2 diabetes: Interaction with SGLT2 inhibitors
Scholtes, Rosalie A., Baar, Michaël J. B., Kok, Megan D., Bjornstad, Petter, Cherney, David Z. I., Joles, Jaap A., Raalte, Daniël H.
Published in Nephrology (Carlton, Vic.) (01.05.2021)
Published in Nephrology (Carlton, Vic.) (01.05.2021)
Get full text
Journal Article